We are international
Donate
TEXT SIZE   


Drug Development and Review: FDA 201

Kay Holcombe, Senior Vice President for Health Policy at the Biotechnology Industry Organization, talks about the current state of drug development and review and how advocates can get involved.

06.03.16


 related articles